Publications by authors named "J Ruessel"

Claim this Profile
S
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.
Markus Moehler, Irina Gepfner-Tuma, Annett Maderer, Peter C Thuss-Patience, Joern Ruessel

BMC Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination.
K Jordan, F Jahn, P Jahn, T Behlendorf, A Stein, J Ruessel

Bone Marrow Transplant· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer.
Stefan Peinert, Wilfried Grothe, Alexander Stein, Lutz P Müller, Joern Ruessel

Ther Adv Med Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis